Thailand - ARV Disputes

Search CPTech
Search Listserves
GlaxoSmithKline Efforts to Patent AZT+3TC
IPR Dispute Over the Antiretroviral Drug Didanosine (ddI)

July 23, 2001. Susannah Markandya. Timeline of Trade Disputes involving Thailand and access to medicines.

October 1, 2002. Aids Access Foundation v. Bristol-Myers Squibb Company Text of the final judgement.

NGO Documents

February 14, 2004. Nathan Ford, David Wilson, Onanong Bunjumnong, and Tido von Schoen Angerer for the Lancet. The role of civil society in protecting public health over commercial interests: lessons from Thailand.

October 9, 2002. MSF press release. The second court case brought by civil AIDS activists against Bristol-Myers Squibb Company Limited (BMS) in which its Thai patent on ddI tablet shall be revoked.

October 7, 2002. MSF Report on the Thai NGO Vicotry Over ddI.

January 22, 2000 letter from James Love to Thomas M. Rosshirt, Foreign Policy Spokesperson for the Vice President, regarding US dispute with Thailand over compulsory license to ddI

April 20, 1999, Letter from James Love to Dr. Stuart Nightingale, U.S. FDA, regarding FDA analyst Dana Delman's letter on ddI to Thai NGOs.

CPTech has more information on the development of and IP rights for ddI on our notes on government role in the development of HIV/AIDS drugs.

Government Documents

February 7, 2000 letter from USTR Charlene Barshefsky to Supachai Panitchpakdi, Thailand's Deputy Prime Minister and Minister of Commerce.

January 27, 2000 letter from Joseph S. Papovich, Assistant U.S. Trade Representative for Services, Investment and Intellectual Property, to Paisan Tan-Ud, the Chairman of PHA Network of Thailand, a Thai NGO.

January 19, 2000, United States Government talking points to the Royal Thai Government on the compulsory licensing of ddI.

November, 1999. Diplomatic Cable from Richard E. Hecklinger, former US Embassador to Thailand, to the US Department of State.

News Coverage

March 1, 2004. Amy Kazmin for the Financial Times. Dose of Optimism in Fighting AIDS.

February 20, 2004. Amy Kazmin for the Financial Times. Thai victory on Aids drug patent paves way for others.

January 17, 2004. Aphaluck Bhatiasevi for the Bangkok Post. US company returns patent for Aids drug.

January 17, 2004. Mukdawan Sakboon for the Nation. US giant gives up right to Aids pill.

October 25, 2003. R. Ramachandran for Frontline Magazine. A Patent War in Thailand.

February 13, 2003. Reuters. Thailand Considers More Generic AIDS Drug Exports.

October 19, 2002. Aphaluck Bhatiasevi for the Financial Times. GPO to soon make tablet form of ddI.

October 1, 2002. Panarat Thepgumpanat for Reuters. Thai court rules against Bristol-Myers on AIDS drug.

October 1, 2002. Uamdao Noikorn for the Associated Press. AIDS activists win court battle against U.S. drug maker.

October 1, 2002. Amy Kazmin for the Financial Times. Thai Aids activists win patent battle.

Domestically Produced "3-in-1" Combination Antiretroviral Pill                        Index

March 21, 2002. The government of Thailand announces its plan to produce a low-priced, comination-therapy antiretroviaral drug. Called GPO-Vir, the pill is a "3-in-1" drug containing stavudine, lamivudine and nevirapine, and it is meant to be taken twice a day. It will be produced by the Government Pharmaceutical Organization, and it will sell for 20 bhat per pill (at the March 21, 2002 exchange rate of 0.023, this equals USD 0.46). A one-month supply will cost 1,200 bhat, or USD 27.66.

July 9, 2004. Amy Kazmin for the Financial Times. Thailand's cheap Aids drugs revive patients' hope.

March 22, 2002. Anjira Assavanonda for the Financial Times. Cocktail Drug on Sale Next Month.

March 22, 2002. Agence France Presse. Thailand to launch dollar-a-day anti-AIDS cocktail.

March 21, 2002. BBC. Thailand offers cheaper Aids treatment.

March 21, 2002. Busaba Sivasomboon for the Associated Press. Thailand produces AIDS cocktail to sell them cheaply.

About Search Events Listserves Blogs Publications